Duke University Medical Center Patient Treatment is a clinical research site located in Durham, North Carolina, United States 27710.
Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.
Duke University Medical Center Patient Treatment has participated in 1 clinical trials.
Therapeutic areas: Sickle Cell Disease (SCD).
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Durham
Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke University Medical Center Patient Treatment has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke University Medical Center Patient Treatment has 1 clinical trials on record. Their work covers Sickle Cell Disease (SCD).
Duke University Medical Center Patient Treatment has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.